Table. 3 PEDro score for methodological quality assessment
Items | Alizad [42] | Benninger [43] | Capacci [44] | Costa-Ribeiro [45] | Costa-Ribeiro [46] | Criminger [47] | da Silva [48] | Dagan [49] | Fernandez-Lago [50] | Kaski [51] | Lattari [52] | Mak [53] | Manenti [54] | Schabrun [55] | Swank [56] | Valentino [57] | Verheyden [58] | Yotnuengnit [59] |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. Specific eligibility criteria | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
2. Subjects random allocation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 1 |
3. Allocation concealment | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 |
4. Similar groups at baseline | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 |
5. Blinding of all subjects | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
6. Blinding of all therapists | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
7. Blinding of all assessors (at least one key outcome) | 0 | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 1 |
8. Data measurement from more than 85% of the subjects initially allocated to groups (at least one key outcome) | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
9. All subjects received the treatment or control condition as allocated (at least one key outcome) | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
10. Between-group comparisons (at least one key outcome) | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 0 |
11. Point measures and measures of variability (at least one key outcome) | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
Total | 4 | 10 | 5 | 9 | 9 | 7 | 9 | 9 | 6 | 9 | 10 | 5 | 8 | 9 | 6 | 8 | 7 | 9 |